Keywords: vertex, gw, start, pivotal, trials, amprenavir, prodrug
Vertex and GW start pivotal trials of amprenavir prodrug in HIV
Article | 29 November 2000
Vertex Pharmaceutcials has been boosted by the announcement thatdevelopment partner Glaxo Wellcome has started two Phase III trials of VX-175/ ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- US Supreme Court says patent settlement can "sometimes" be illegal
- Negative US patent ruling for Novo Nordisk on Prandin
- Daiichi Sankyo files for Japanese approval of Prasugrel
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
